Qinglian Wen

2.6k citations
67 papers · 1.6k indexed · 1 hit paper · h-index 24
Topics
Cancer Immunotherapy and Biomarkers (13 papers)Cancer-related molecular mechanisms research (9 papers)RNA modifications and cancer (7 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEScientific Reports
Partner nations
ChinaHong KongIran

In The Last Decade

Qinglian Wen

61 papers receiving 1.6k citations

Hit Papers

VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-smal...202220262023202420224080120

Peers

Qinglian Wen
Comparison fields: 5 of 107
  • Molecular Biology 755
  • Oncology 534
  • Cancer Research 423
  • Immunology 327
  • Pulmonary and Respiratory Medicine 275
Replace Ying Hu with:
Ying Hu China
Bangwei Cao China
Hongcheng Zhu China
Xinchen Sun China
Johannes Lemke Germany
Pei Zhang China
Suimin Qiu United States
Qinglian Wen relative to Ying Hu China Ying Hu's profile →
Citations per field
00.5×
Ying Hu · 1×
Citations per year

Countries citing papers authored by Qinglian Wen

Since Specialization
Citations

This map shows the geographic impact of Qinglian Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglian Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglian Wen more than expected).

Fields of papers citing papers by Qinglian Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinglian Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglian Wen. The network helps show where Qinglian Wen may publish in the future.

Co-authorship network of co-authors of Qinglian Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Qinglian Wen. A scholar is included among the top collaborators of Qinglian Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinglian Wen. Qinglian Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 12
3 0
4 1
5 1
6 5
7 20
8 20
9 31
10 27
11 16
12 18
13 26
14 44
15 37
16 23
17 15
18 121
19 3
20 24

About Qinglian Wen

Qinglian Wen is a scholar working on Oncology, Cancer Research and Obstetrics and Gynecology, having authored 67 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), Cancer-related molecular mechanisms research (9 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Cancer Research (423 citations), Oncology (534 citations) and Immunology (327 citations). Qinglian Wen has collaborated with scholars based in China, Hong Kong and Iran. Frequent co-authors include Zhangang Xiao, Mingxing Li, Yueshui Zhao, Jing Shen, Xu Wu, Fukuan Du, Parham Jabbarzadeh Kaboli, Jing Li, Chi Hin Cho and Tao Yi. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026